Weight loss of up to 13% achieved in three months with once-a-day tablet, Phase I trial finds

Credit: Unsplash/CC0 Public Domain Individuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, according to a presentation at the

New research could lead to genetically tailored diets to treat patients with IBS

An international study has found that genetic variations in human carbohydrate-active enzymes may affect how people with irritable bowel syndrome (IBS) respond to a carbohydrate-reduced diet. The research, which is

Weight-adjusted waist index positively tied to overactive bladder

The weight-adjusted waist index (WWI) may be able to predict future incidence of overactive bladder (OAB) in adults, according to a study published online Sept. 3 in Frontiers in Nutrition.